ITI Securities Broking Ltd

Change Company Name

Concord Biotech Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 543960	ISIN Demat INE338H01029	Book Value 99.71	NSE Symbol CONCORDBIO	Div & Yield % 0.58	Market Cap (₹ Cr.) 13,708.91	P/E 46.14	EPS 14.2	Face Value 1

Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
SOURCES OF FUNDS :	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Share Capital	10.46	10.46	10.46	10.46	9.51	9.51
Reserves Total	2,009.29	1,802.18	1,514.79	1,281.52	1,097.65	990.16
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	2,019.75	1,812.64	1,525.25	1,291.98	1,107.16	999.67
Secured Loans	0.00	0.38	6.23	31.24	60.59	86.35
Unsecured Loans	0.63	2.59	3.51	0.31	1.91	2.93
Total Debt	0.63	2.97	9.74	31.55	62.50	89.28
Other Liabilities	3.72	2.82	1.96	2.30	1.87	2.10
Total Liabilities	2,024.10	1,818.43	1,536.95	1,325.83	1,171.53	1,091.05
APPLICATION OF FUNDS :	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Gross Block	1,158.91	1,095.41	825.51	791.69	719.94	644.29
Less : Accumulated Depreciation	372.50	300.73	250.20	198.71	146.97	98.08
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	786.41	794.68	575.31	592.98	572.97	546.21
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	79.32	50.66	211.48	172.70	74.16	17.95
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	487.69	335.20	244.37	137.72	74.39	141.65
Current Assets, Loans & Advances	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Inventories	325.69	239.67	207.95	212.31	195.12	153.61
Sundry Debtors	460.60	521.65	349.61	273.76	232.17	177.52
Cash and Bank Balance	9.28	1.18	47.02	43.45	88.93	60.82
Loans and Advances	47.58	56.20	47.94	61.25	42.97	74.22
Total Current Assets	843.15	818.70	652.53	590.77	559.19	466.16
Less : Current Liabilities and Provisions	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Current Liabilities	155.83	166.06	124.91	128.91	119.21	73.68
Provisions	11.24	15.67	9.40	36.47	1.75	0.66
Total Current Liabilities & Provisions	167.07	181.73	134.30	165.39	120.96	74.34
Net Current Assets	676.08	636.97	518.23	425.39	438.23	391.82
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	5.55	4.13	2.45	2.18	1.95	0.60
Deferred Tax Liability	50.91	38.15	30.52	25.62	22.92	18.05
Net Deferred Tax	-45.36	-34.02	-28.07	-23.44	-20.97	-17.45
Other Assets	39.96	34.94	15.62	20.48	32.74	10.87
Total Assets	2,024.11	1,818.43	1,536.95	1,325.83	1,171.52	1,091.05
Contingent Liabilities	3.76	3.91	14.31	14.31	13.32	3.89

Balance Sheet

Market

News

Research

TECHNICAL

FUNDAMENTAL

Products

Attention Investors